Todd P. Branning - Mar 16, 2023 Form 4 Insider Report for NeuBase Therapeutics, Inc. (NBSE)

Signature
/s/ Todd P. Branning
Stock symbol
NBSE
Transactions as of
Mar 16, 2023
Transactions value $
$0
Form type
4
Date filed
3/17/2023, 04:11 PM
Previous filing
Nov 4, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NBSE Common stock Award $0 +54.2K +180.67% $0.00 84.2K Mar 16, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units to be settled by the issuance of one share of common stock for each restricted stock unit that is earned; 25% of which shall vest on March 16, 2024 and the remainder of which shall vest monthly thereafter until March 16, 2027, provided that vesting shall only occur on a scheduled vesting date if employment has not terminated prior to such vesting date, inclusive. Restricted stock units are subject to accelerated vesting, subject to certain conditions, in the event of a change of control of the Issuer.